Literature DB >> 30584923

Repeated switches between reference product etanercept and biosimilar do not affect disease activity or retention rate of etanercept over 24 months - a cohort study with historical controls.

Valgerdur Sigurdardottir1, Anna Svärd2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30584923     DOI： 10.1016/j.jbspin.2018.12.003

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  1 in total

Review 1.  Real-World Evidence on Etanercept Biosimilar SB4 in Etanercept-Naïve or Switching Patients: A Systematic Review.

Authors:  Hans C Ebbers; Burkhard Pieper; Amine Issa; Janet Addison; Ulrich Freudensprung; Mourad F Rezk
Journal:  Rheumatol Ther       Date:  2019-08-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.